Multidrug resistance-associated proteins are crucial for the viability of activated rat hepatic stellate cells

Hepatology

Volumn 48, Issue 2, 2008, Pages 624-634

  Hannivoort, Rebkka A ^a   Dunning, Sandra ^a   Borght, Sara Vander ^b   Schroyen, Ben ^c   Woudenberg, Jannes ^a   Oakley, Fiona ^d   Buist Homan, Manon ^a   van den Heuvel, Fiona A J ^a   Geuken, Mariska ^a   Geerts, Albert ^c   Roskams, Tania ^b   Faber, Klaas Nico ^a   Moshage, Han ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ACRIDINE; CASPASE 3; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; MULTIDRUG RESISTANCE PROTEIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER FIBROSIS; MALE; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; STELLATE CELL;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELL SURVIVAL; CELLS, CULTURED; HEPATOCYTES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1BETA; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OXIDATIVE STRESS; P-GLYCOPROTEINS; RATS; RATS, WISTAR; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 49649104026     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22346     Document Type: Article

References (32)

1. Schoemaker MH, Moshage H. Defying death: The hepatocyte's survival kit. Clin Sci (Lond) 2004;107:13-25.
2. Kaplowitz N. Mechanisms of liver cell injury. J Hepatol 2000;32(Suppl): 39-47.
3. Sell S. Heterogeneity and plasticity of hepatocyte lineage cells. HEPATOLOGY 2001;33:738-750.
4. Friedman SL. Liver fibrosis - from bench to bedside. J Hepatol 2003; 38(Suppl 1):S38-S53.
5. Libbrecht L, Roskams T. Hepatic progenitor cells in human liver diseases. Semin Cell Dev Biol 2002;13:389-396.
6. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-218.
7. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 2002;65:166-176.
8. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247-2250.
9. Svegliati-Baroni G, Ridolfi F, Hannivoort R, Saccomanno S, Homan M, De MS, et al. Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor. Gastroenterology 2005;128: 1042-1055.
10. Elsharkawy AM, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 2005;10:927-939.
11. Borst P, Elferink RO. Mammalian ABC transporters in health and disease. Annu Rev Biochem 2002;71:537-592.
12. Faber KN, Muller M, Jansen PL. Drug transport proteins in the liver. Adv Drug Deliv Rev 2003;55:107-124.
13. Higgins CF. Multiple molecular mechanisms for multidrug resistance transporters. Nature 2007;446:749-757.
14. Ros JE, Roskams TA, Geuken M, Havinga R, Splinter PL, Petersen BE, et al. ATP binding cassette transporter gene expression in rat liver progenitor cells. Gut 2003;52:1060-1067.
15. Vander BS, Libbrecht L, Katoonizadeh A, van PJ, Cassiman D, Nevens F, et al. Breast cancer resistance protein (BCRP/ABCG2) is expressed by progenitor cells/reactive ductules and hepatocytes and its expression pattern is influenced by disease etiology and species type: Possible functional consequences. J Histochem Cytochem 2006;54:1051-1059.
16. Cassiman D, Denef C, Desmet VJ, Roskams T. Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. HEPATOLOGY 2001;33:148-158.
17. Moshage H, Casini A, Lieber CS. Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes. HEPATOLOGY 1990;12(pt 1):511-518.
18. Wright MC, Issa R, Smart DE, Trim N, Murray GI, Primrose JN, et al. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 2001; 121:685-698.
19. Schoemaker MH, Gommans WM, Conde de la RL, Homan M, Klok P, Trautwein C, et al. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. J Hepatol 2003;39:153-161.
20. Gekeler V, Ise W, Sanders KH, Ulrich WR, Beck J. The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem Biophys Res Commun 1995;208:345-352.
21. Mickley LA, Bates SE, Richert ND, Currier S, Tanaka S, Foss F, et al. Modulation of the expression of a multidrug resistance gene (mdr-1/ P-glycoprotein) by differentiating agents. J Biol Chem 1989;264:18031-18040.
22. Boesch D, Gaveriaux C, Jachez B, Pourtier-Manzanedo A, Bollinger P, Loor F. In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833. Cancer Res 1991;51:4226-4233.
23. Iimuro Y, Nishiura T, Hellerbrand C, Behrns KE, Schoonhoven R, Grisham JW, et al. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 1998;101:802-811.
24. Blokzijl H, Vander BS, Bok LI, Libbrecht L, Geuken M, van den Heuvel FA, et al. Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels. Inflamm Bowel Dis 2007;13:710-720.
25. Tuyt LM, Bregman K, Lummen C, Dokter WH, Vellenga E. Differential binding activity of the transcription factor LIL-STAT in immature and differentiated normal and leukemic myeloid cells. Blood 1998;92:1364-1373.
26. Zhou G, Kuo MT. NF-kappaB-mediated induction of mdr1b expression by insulin in rat hepatoma cells. J Biol Chem 1997;272:15174-15183.
27. Ros JE, Libbrecht L, Geuken M, Jansen PL, Roskams TA. High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease. J Pathol 2003;200:553-560.
28. Deng L, Lin-Lee YC, Claret FX, Kuo MT. 2-Acetylaminofluorene upregulates rat mdr1b expression through generating reactive oxygen species that activate NF-kappa B pathway. J Biol Chem 2001;276:413-420.
29. Res JE, Schuetz JD, Geuken M, Streetz K, Moshage H, Kuipers F, et al. Induction of Mdr1b expression by tumor necrosis factor-alpha in rat liver cells is independent of p53 but requires NF-kappaB signaling. HEPATOLOGY 2001;33:1425-1431.
30. Lee G, Piquette-Miller M. Cytokines alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays. J Pharm Sci 2003;92:2152-2163.
31. Schoemaker MH, Ros JE, Homan M, Trautwein C, Liston P, Poelstra K, et al. Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. J Hepatol 2002;36:742-750.
32. Hammond CL, Marchan R, Krance SM, Ballatori N. Glutathione export during apoptosis requires functional multidrug resistance-associated proteins. J Biol Chem 2007;282:14337-14347.